suchen
Surgical PR

During Endometriosis Awareness Month, Lumenis Marks Exciting Study Outcomes for its Breakthrough Surgical Intervention

CO2 laser excision of endometrial cells reduces pain and recurrence while preserving fertility

March 26th, 2018 – Yokneam, Israel.

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced the publication of meaningful new clinical evidence for its surgical intervention for patients with endometriosis. Lumenis is excited to share this message of hope and innovation for women with this historically misunderstood disease as part of the company’s annual support of Endometriosis Awareness Month.

Lumenis Announces New Clinical Breakthroughs Using its Patent-Protected MOSES Technology

Reduction in Lithotripsy procedure time and benefits in BPH treatments

March 16th, 2018 – Yokneam, Israel.

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the release of significant new clinical evidence in lithotripsy as well as initial clinical benefits in benign prostatic hyperplasia (BPH) treatments using the MOSES™ Technology at the 33rd annual European Association of Urology Congress (EAU18), taking place in Copenhagen, March 16-19, 2018.

Lumenis to Highlight the Positive Impact of its FiberLase™ CO2 Laser Treatment for Ovarian Endometrioma on Ovarian Reserve

Presenters will feature results of recent successful studies using the innovative technology and its unique operative technique.

October 18th, 2017 – Yokneam, Israel.

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced today that it will share new clinical data on its CO2 laser-based FiberLase™ for minimally-invasive treatment of endometriosis at the European Society for Gynecological Endoscopy (ESGE) 26th Annual Congress, October 18- 21 at the Sueno Hotel Belek & Convention Center in Antalya, Turkey.

Lumenis Launches Its New Moses™ Holmium Technology in the American Urological Association Annual Meeting

Revolutionizing stone fragmentation and stone dusting

May 12th, 2017 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced the launch of its new Moses™ Holmium technology during the 112th American Urological Association (AUA) annual meeting in Boston. The AUA launch of Moses follows a successful introduction of the technology during the last European Association of Urologists (EAU) annual congress in London, where hundreds of physicians had a firsthand experience of the Moses technology – stressing its truly innovative nature and potential to revolutionize the world of holmium laser lithotripsy.

Dedicated to Women’s Health Lumenis Announces Support of Fourth Annual Worldwide Endometriosis March

Improving public awareness of this high prevalent disease may help women by encouraging earlier diagnosis and proper treatment.

March 24, 2017 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced today their support of the fourth annual Worldwide Endometriosis March (EndoMarch), an international event bringing together women and supporters to raise awareness of endometriosis. This year’s EndoMarch will be celebrated on Saturday, March 25, 2017, while the entire month of March is dedicated to awareness efforts and empowering women with education and knowledge.

PB-2008091 Rev A

RSS
12345678